Vincent Liu

Managing Director and Chief US Representative
Fosun Pharma

Dr. Liu joined International Business Division of Shanghai Fosun Pharmaceutical Group in 2009 to lead the effort in executing Fosun Pharma’s investment and M&A strategies in the North America region. Upon joining the company, Dr. Liu has made significant contribution to implanting Fosun Pharma’s international strategies. His achievements including helping the company to raise a $500 million private equity fund from oversea and setting up two JVs with large US and Canadian companies in China. Currently Dr. Liu is focused on helping Wanbang and Fosun Pharma to acquire more product and technology for the Chinese market.

Before joining Fosun Pharma, he served in several Chinese and US startup companies as well as a healthcare focused PE/VC fund.

Dr. Liu received his Ph.D. degree in Molecular Biology in Drexel University and MBA degree from University of Rochester.

Check out the incredible speaker line-up to see who will be joining Vincent.

Download The Latest Agenda

Day 2

Sunday, April 10th, 2016

13:45 PANEL: Exploring Opportunities And Overcoming Challenges To Do Business In China And Other Emerging Markets

• Determining why there is a big appetite for acquiring companies and licensing in China; how does China factor into biopharma’s plans for the future?

• The Wild, Wild West: Developing a strategy to overcome issues in regulatory approval, reimbursement, and more

• Establishing which product profiles work in China and which do not

• Outlining successes, challenges, and lessons learned in working in China and other emerging markets